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During the past 15 years, the curriculum content for nonprescription medication and self-care thera-
peutics has expanded significantly. Self-care courses ranging from stand-alone, required courses to
therapeutic content and skills laboratories, have evolved in colleges and schools of pharmacy to
accommodate rapid changes related to nonprescription medications and to meet the needs of students.
The design of and content delivery methods used in self-care courses vary among institutions. Teaching
innovations such as team-based learning, role playing/vignettes, videos, and social media, as well as
interdisciplinary learning have enhanced delivery of this content. Given that faculty members train
future pharmacists, they should be familiar with the new paradigms of Nonprescription Safe Use
Regulatory Expansion (NSURE) Initiative, nonprescription medications for chronic diseases, and
the growing trends of health and wellness in advancing patient-care initiatives. This paper reviews
the significant changes that may be impacting self-care curriculums in the United States.
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INTRODUCTION
In 2012, the Nonprescription Medicines Academy
(NMA) and the Self-Care Institute (SCI) celebrated their
15 and 10 year anniversaries, respectively. These anni-
versaries have encouraged reflection on the vast changes
in self-care education, the growing role of nonprescrip-
tion medicine in health care, and the value of faculty de-
velopment programming to support facultymemberswho
teach self-care in the pharmacy curriculum. During the
past 15 years, the curriculum content for nonprescription
medication and self-care therapeutics has expanded sig-
nificantly. New nonprescription products, formulation
modifications, safety concerns, and regulatory changes
are impacting the evolving responsibilities of the phar-
macist in self-care. With these changes, self-care
courses also transform to include innovative teaching
strategies as pharmacy students needs in this area become
greater. This paper reviews the significant changes that
may be impacting self-care curriculums in the United
States.
MILESTONES IN SELF-CARE OVER THE
PAST 15 YEARS
The nonprescription medication marketplace has
grown extensively over the last 15 years. There are now
more than 300,000 nonprescription medication products
in 80 therapeutic classes marketed in the United States.1
This number has increased twofold since 2001 when just
more than 100,000 nonprescription medication products
were on themarket.2 A contributing factor to this increase
is the recent rise in prescription medications now being
available in nonprescription formulation (prescription to
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nonprescription switches), allowing medications that
once required a prescription to be purchased without one.
During this timeframe, more than 35 products have
come to the market either directly as a nonprescription
medication or as a prescription to nonprescription switch.
Table 1 highlights major changes to the nonprescription
market during this timeframe.3,4 In 2002, loratadine
(Claritin) became thefirst second-generation antihistamine
available without a prescription. This prescription to
nonprescription switch revolutionized the treatment of
seasonal and perennial allergies by providing the first non-
sedating antihistamine option. It also changed managed-
care pharmacy, as many pharmacy-benefit managers
removed second-generation antihistamines from their
formularies, forcing patients to use nonprescription med-
ications as an initial therapeutic approach.






Switches Ingredients Product Examples (Manufacturers)
1997 6 cromolyn sodium, tioconazole, loperamide/
simethicone, triclosan, ketoconazole,
minoxidil
Nasalcrom (McNeil Consumer), Vagistat-1
(Bristol-Meyers Squibb), others, Imodium
Advanced (McNeil Consumer), Total
(Colgate – Palmolive), Nizoral (Johnson
& Johnson), Rogaine Extra Strength for
Men (Johnson & Johnson)
1998 1 miconazole nitrate Monistat 3 (Advanced Care Products)
1999 3 terbinafine hydrochloride, cimetidine
suspension, naproxen sodium/
pseudoephedrine
Lamisil AT (Novartis), Tagamet HB 200
(GlaxoSmithKline), Aleve Cold & Sinus
(Bayer Consumer Care)
2000 2 docosanol, famotidine/calcium carbonate/
magnesium hydroxide
Abreva Cream (Avanir Pharmaceuticals),
Pepcid Complete (J&J/Merck)
2001 1 butenafine hydrochloride Lotrimin Ultra (Schering-Plough)









2003 1 omeprazole magnesium Prilosec OTC (Procter & Gamble)
2004 2 guaifenesin/dextromethorphan, guaifenesin/
pseudoephedrine
Mucinex DM (Adams Respiratory
Therapeutics), Mucinex D (Adams
Respiratory Therapeutics)
2005 1 diphenhydramine citrate or hydrochloride/
ibuprofen
Advil PM (Wyeth)
2006 4 ecamsule (sunscreen), levonorgestrel,
polyethylene glycol 3350, ketotifen
Anthelios SX (L’Oreal), Plan B (Duramed),
MiraLAX (Schering-Plough), Zaditor
(Novartis)
2007 3 orlistat, cetirizine/pseudoephedrine, cetirizine alli (GlaxoSmithKline), Zyrtec-D (McNeil),
Zyrtec (McNeil)
2008 0
2009 3 lansoprazole, levonorgestrel, omeprazole/
sodium bicarbonate
Prevacid 24 HR (Novartis), Plan B One Step
(Schering-Plough), Zegerid OTC
(Schering-Plough)
2010 1 ibuprofen/phenylephrine Advil Congestion Relief (Pfizer)
2011 2 fexofenadine, fexofenadine/pseudoephedrine Allegra (Chattem), Allegra-D (Chattem)
2012 0
2013 2 oxybutynin transdermal system, triamcinolone
acetonide
Oxytrol for Women (Merck), Nasacort
Allergy 24 HR (Sanofi)
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In 2003, omeprazole (PrilosecOTC) became the first
proton-pump inhibitor (PPI) available without a prescrip-
tion. This prescription to nonprescription switch trans-
formed the treatment of frequent heartburn by providing
patients an option beyond antacids and H2-antagonists. It
also allowed pharmacy-benefit managers to implement
step-therapy in their formularies, requiring patients to
first use nonprescription omeprazole before trying pre-
scription PPIs.
In 2006, levonorgestrel (Plan B) became the first
dual-labeled product, ie, available as both a prescription
and nonprescription, depending on patient age. Emer-
gency contraception available without a prescription pro-
vides thousands ofwomen increased access,whichwill be
further increased now that the age limit has been lifted.5
In 2007, orlistat (alli) became the first nonprescription
weight-loss medication to receive approval by the Food
and Drug Administration (FDA). This prescription to
nonprescription switch capitalized on the growing health
and wellness trend, providing patients a weight-loss op-
tion that, when combined with diet and physical activity,
is safer than stimulant products. This movement has ex-
panded further to include chronic conditions with the re-
cent 2013 switch of oxybutynin patch to treat overactive
bladder and triamcinolone acetonide for nasal allergy
symptoms.6,7
During the past 15 years, dozens of safety concerns
have been raised and regulations have been instituted in
the nonprescription medicine area. In 2005, the Combat
Methamphetamine Epidemic Act was passed. This fed-
eral statute placed restrictions on pseudoephedrine sales
and access and implemented reporting requirements.7
States have passed additional laws regarding restrictions
to pseudoephedrine. Another regulatory issue occurred
a year later with the passage of the Dietary Supplement
andNonprescriptionDrugConsumer ProtectionAct. This
act required manufacturers, packers, distributers, and re-
tailers to record and report adverse events.8 Regulations
requiring current Good Manufacturing Practices for di-
etary supplements became law in 2006. This ruling en-
sures the quality of supplements by setting guidelines
related to the manufacturing, labeling, and holding of
these products; however, it does not provide additional
safety, effectiveness, and dissolution evidence that is
greatly needed.9 In 2007, the FDA rejected the prescrip-
tion to nonprescription switch of a statin for the third
time.10 Pediatric cough and cold products were recalled,
relabeled, and are still being investigated for appropriate-
ness in children 2-11 years old.11 Acetaminophen labeling
and formulations for infants, children, and adults have also
undergone changes to ensure safe usage.12 Historically,
prescription to nonprescription changes have involved
medications that treat acute problems (symptoms lasting
less than 2 weeks). However, the most recent switches of
2013 are now dealing with more chronic issues and could
increase the potential for further concerns in the future.
Significant changes in growing therapeutic cate-
gories as well as regulatory and safety concerns have
impacted content delivered in self-care curricula. Both
the SCI and NMA have been at the forefront of providing
the most up-to-date information regarding these products
to assist self-care faculty members with the integration of
this information into both classroom and experiential
teaching. The NMA Facebook page has been a resource
highlighting these updates in nonprescription news, and
editorial board members from SCI provide chapter up-
dates through the American Pharmacists Association’s
Handbook of Nonprescription Drugs.13,14
SELF-CARE EDUCATION
During this 15-year time period, there also have been
great strides in self-care within pharmacy education. The
blueprint for the North American Pharmacists Licensure
Examination (NAPLEX)was revised in 2005 to recognize
the importance of nonprescription medicines, eliminating
any distinction of importance between prescription and
nonprescription medicines.15,16 The Journal published
a Nonprescription Medicines and Self-Care theme issue
in 2006, which featured several articles reinforcing the
importance of self-care instruction. Part of this supple-
ment identifies the pharmacist as the “only health profes-
sional who receives in-depth formal education and skill
development in nonprescription drug therapy.”17 Shortly
after this publication, the 2007 Accreditation Standards
and Guidelines for the Professional Program in Pharmacy
Leading to the Doctor of Pharmacy Degree stated that
education relating to nonprescription medicines and
self-care should be incorporated throughout the pharmacy
curriculum, including introductory and advanced phar-
macy practice experiences (IPPEs andAPPEs). Guidance
regarding the incorporation of self-care and nonprescrip-
tion medicines into the pharmacy curriculum can be
found in Appendix B, C, and D of the accreditation stan-
dards.18 Establishment of the American Association of
Colleges of Pharmacy Self-Care Therapeutics/Nonpre-
scription Medicines Special Interest Group (SIG) soon
followed, providing another opportunity for self-care fac-
ulty to network, learn, and promote the scholarship of
self-care education.19 Practicing pharmacists are also en-
hancing their self-care knowledge through continuing ed-
ucation opportunities such as the National Alliance of
State Pharmacy Associations partnership with NMA to
conduct Student Pharmacists Self-Care Championships,
which are held nationwide at annual state pharmacy
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conventions.20 These events are often led by local self-
care faculty members as student teams compete in an
event similar to a quiz bowl, during which they answer
questions developedbyNMAfacultymembers andwhich
may involve continuing education credit.
Self-care instruction is incorporated into the phar-
macy curriculum in many ways. Some colleges and
schools require it to be a standalone course, while others
offer it as an elective. Still others may integrate the cur-
riculum within existing therapeutics courses, simulation
laboratories, or in IPPEs and APPEs.21 Various methods
have been used to assist with self-care instruction in the
classroom. Although lecture is still the most common
mode of delivery, active-learning strategies appear to be
a growing trend.22-24 Use of active-learning strategies in
the classroom to support and develop a student’s ability to
critically think and problem solve has been well estab-
lished. There are several active-learning strategies that
could be incorporated into the self-care curriculum from
think-pair-share, one-minute reflection, or the muddiest
point exercises; to more complex activities, such as role-
playing, problem-based learning, case-based learning, and
team-based learning. Additionally, there are technology-
based active-learning activities, such as audience-response
systems, videos, and social media, that can be incorpo-
rated to engage students in their learning. Several strate-
gies discussed herein have been incorporated into NMA
and SCI programming to assist and encourage faculty
members to use various methods to enhance the delivery
of self-care instruction. Faculty members are regularly
invited to present poster/platform presentations and
roundtable discussions to share their innovations in teach-
ing.25,26 Faculty resources, including complex cases, assess-
ment questions, grading tools, syllabi, active-learning
techniques and strategies are available on the NMAweb-
site. The SCI also makes available resources from the
annual meetings and editors continually provide updates
through the APhA Library and Pharmacy Today articles.
Two key learning components in the self-care cur-
riculum are effective communication and patient assess-
ment. The pharmacist must be able to effectively and
efficiently ask the patient pertinent questions to determine
the problem, the most bothersome symptoms, other med-
ical conditions, andmedications being used.Role-playing
and vignettes are strategies that can be used to teach these
skills. Scenarios can be created and the students can then
act out what they would do for the patient. The faculty
member can assess and evaluate the students not only on
the process used (ie, communication skills and critical
thinking) but also on their nonprescription medication
knowledge. Role-playing activities wherein students
engage in patient consultations also can be used to develop
social emotional competences.27 There is a growing body
of evidence to support the use of this type of active learning
in the classroom to meet the educational needs of future
pharmacists and ensure they develop necessary skills.28-35
Team-based learning (TBL) is a type of collaborative
learning that shifts the focus of classroom time from a lec-
ture format to the application of key concepts. This type of
learning is sometimes called the “flipped classroom” be-
cause it requires students to acquire the initial content
through readings, online presentations, or other resources
prior to class. At the beginning of class, students are
assessed on the preclass requirements bymeans of aRead-
iness Assurance Technique (RAT). Both individual as-
sessments (I-RAT) and group assessments (G-RAT) are
completed at the beginning of class. Having both RATs
holds the students accountable for being prepared for
class. Following the completion of both RATs, the re-
mainder of the class is spent on application-type activi-
ties, such as case discussions, ethical dilemmas, and pro/
con discussions. Use of TBL is emerging in the develop-
ment and delivery of self-care therapeutics.36-39
Pharmacy school curricula have expanded to incor-
porate YouTube projects and Facebook campaigns in
self-care and public health courses. This strategy is in-
tended to expand the skills and abilities of pharmacy stu-
dents in reaching the community at large with succinct
self-care messages. The purpose of these messages is to
stress the safe use of nonprescription medications and to
promote the role of pharmacists in assisting and educating
patients regarding self-care products.40 Example projects,
course outcomes, and evidence of student impact have
been presented at NMA, enabling other colleges and
schools of pharmacy to consider adopting a similar ap-
proach in their courses. The use of YouTube for patient
education is an area in which further research is needed to
determine the impact that videos have on patients’ un-
derstanding of their medications, improving adherence,
and reducing medications errors and adverse events. So-
cial media content could be considered as labeling and
advertisement of these products, which is under the juris-
diction of the FDA.41 FDA guidance and regulations re-
garding social media messaging will be an important
statement for colleges and schools of pharmacy that are
using media as an instructional tool to review and inte-
grate into their curricula. 42
THE FUTURE OF SELF-CARE
Nonprescription Safe Use Regulatory Expansion
(NSURE) Initiative
In 2012, the FDA announced it was looking at ways
to approve the use of prescription medications by making
them available as nonprescription through conditions of
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safe use. Under the FDA’s NSURE Initiative, the “condi-
tions of safe use” could include pharmacist interventions
or innovative technologies. Manufacturers can submit an
application to the FDA for review and consideration. The
FDA states that this paradigm could address the public
health problem of under-treatment of common condi-
tions.43,44 Other FDA considerations for this paradigm
include: allowing some medication products that require
an initial prescription to be available for refills without
a prescription,with a condition of safe use for that purpose
and permitting some drug products to be available by
prescription and without a prescription simultaneously,
with conditions of safe use.
This potential new paradigm is important to pharma-
cists, as it would serve as an opportunity for them to
communicate and collaborate with the medical commu-
nity to improve team-based care; reconnect and refer into
the healthcare system those patients whomay have under-
treated chronic conditions or may need expanded access
to life-saving rescue medications; and leverage patients’
access to pharmacists to safely increase the availability of
certain medications, as pursued by manufacturers for non-
prescription approval as developed within this initiative.45
Although the FDA is considering the NSURE Initia-
tive, not all healthcare professions support this action. In
June 2012, the American Medical Association House of
Delegates adopted resolution 235, which was in opposi-
tion to the FDA’s Rx to OTC Paradigm Shift.46 The steer-
ing committee and editorial boards for NMA and SCI
have incorporated regulatory issues such as NSURE into
their programming when relevant so that self-care faculty
members can share it with students in the classroom and
with practicing pharmacists at the state level.
Health and Wellness Initiatives
AsmoreAmericans have become increasingly aware
of their health, there is a growing trend toward disease
prevention and maintaining healthy lifestyles. Although
pharmacists have traditionally been available to offer ad-
vice and education on disease states, they are equally
capable of offering advice and education on how to pre-
vent disease through healthy lifestyles and information on
nutritional supplementation, such as dietary supplements.
Over the past 3 to 4 years, most pharmacy retailers
are encouraging pharmacists to offer wellness services to
their patients.47-50 These include blood pressure and cho-
lesterol screenings, blood glucose testing, risk assess-
ments for chronic obstructive pulmonary disease and
diabetes, immunizations, and weight-loss management.
Some pharmacies even offer organic foods and fresh pro-
duce while nutrition experts educate patients on the ben-
efits of healthy, nutritious foods.
Many insurance companies and employers are offer-
ing incentives for members to participate in wellness ini-
tiatives. The majority of services are offered free of
charge to patients. Most of the financial benefits seen in
pharmacies stem from increased sales of wellness prod-
ucts. Billing for pharmacy services not linked to a product,
including wellness services, has traditionally been a chal-
lenge for pharmacists because they are not able to bill for
cognitive services under their own National Provider
Identification number but must collaborate with another
provider or insurance company to gain reimbursement for
services.
As Americans take control of their health through
wellness initiatives, the pharmacist’s role becomes in-
creasingly more important in the overall well-being of
our patients. SCI and NMA continue to play a key role
in providing self-care educators resources for preparing
the next generation of pharmacists. Just as self-care has
become more preventative, SCI and NMA have followed
this trend, consistently incorporating topics related to
health, wellness, and disease prevention and expanding
on nonpharmacological measures, appropriate use of di-
etary supplements, and the growing role of home-based
health-monitoring devices. Although current legislation
does not allow for full reimbursement of services, we
anticipate that future healthcare reformwill give pharma-
cists the opportunity to be engaged in health and wellness
initiatives.
CONCLUSION
Self-care has evolved and will continue to grow as
patients become more empowered and medications that
once were available only by prescription become more
readily availablewithout a prescription. Pharmacists have
a vital role in triaging and assisting patients in the selec-
tion of themost appropriate treatment option. As self-care
continues to expand, it is imperative that pharmacy col-
leges and schools meet the challenges of educating future
pharmacists to effectively assist patients in this area. Al-
though changes have been made in self-care curricula,
there is a great need for outcomes research to evaluate
how well this challenge is being met.
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